FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078239209> ?p ?o ?g. }

• W2078239209 endingPage "271" @default.
• W2078239209 startingPage "268" @default.
• W2078239209 abstract "Objective Antidoping codes in sport are intended to deter and sanction athletes using performance-enhancing agents while promoting an even playing field for all competitors. Although the World Anti-Doping Code (WADC) permits anticonvulsants in general, harmonization of antidoping permits an international sport federation (IF) to prohibit specific medications within that IF. The anticonvulsants levetiracetam, tiagabine, and lamotrigine may pose ethical dilemmas and could be considered violations of antidoping codes. Method This study is a literature review with analysis. Results Lamotrigine, with antiglutamatergic and sodium channel properties, is FDA-approved for maintenance treatment of bipolar disorder, in addition to its use in the treatment of major depression, anxiety disorders, and schizophrenia. Tiagabine, a selective GABA reuptake inhibitor, has mood-stabilizing and anxiolytic properties. Levetiracetam, whose unique mechanism involves the modulators β-carboline and zinc, has anxiolytic and mood-stabilizing properties. Anxiolytics, antidepressants, and antipsychotics are banned in archery; under strict liability, all three anticonvulsants violate WADC/IF for that specific sport and could result in disqualification unless therapeutic use exemptions (TUEs) are obtained. Ethical issues regarding the use of anticonvulsants by athletes and the need to obtain TUEs are addressed. Conclusion The WADC with harmonized IF policies are meant to prevent doping by athletes, but not appropriate medical treatment. When anticonvulsants have other psychotropic properties, ethical issues arise. Athletes should list all medications taken with diagnoses, obtain TUEs as indicated, and contact the appropriate IF or Olympic organization to determine the status of the proposed medication (banned, restricted, nonbanned). Further, clinicians should be knowledgeable regarding these issues when treating athletes." @default.
• W2078239209 created "2016-06-24" @default.
• W2078239209 creator A5054440404 @default.
• W2078239209 date "2007-03-01" @default.
• W2078239209 modified "2023-09-26" @default.
• W2078239209 title "Anticonvulsants in sports: Ethical considerations" @default.
• W2078239209 cites W1964838666 @default.
• W2078239209 cites W1965886947 @default.
• W2078239209 cites W1967829059 @default.
• W2078239209 cites W1968183674 @default.
• W2078239209 cites W1968828764 @default.
• W2078239209 cites W1970908493 @default.
• W2078239209 cites W1973713790 @default.
• W2078239209 cites W1977016493 @default.
• W2078239209 cites W1978355717 @default.
• W2078239209 cites W1979650035 @default.
• W2078239209 cites W1984374140 @default.
• W2078239209 cites W1988231635 @default.
• W2078239209 cites W1990333646 @default.
• W2078239209 cites W1994008100 @default.
• W2078239209 cites W1997253011 @default.
• W2078239209 cites W2004098426 @default.
• W2078239209 cites W2004858786 @default.
• W2078239209 cites W2011785379 @default.
• W2078239209 cites W2013207045 @default.
• W2078239209 cites W2014113421 @default.
• W2078239209 cites W2015097609 @default.
• W2078239209 cites W2020726187 @default.
• W2078239209 cites W2023448340 @default.
• W2078239209 cites W2026151186 @default.
• W2078239209 cites W2032132493 @default.
• W2078239209 cites W2035633504 @default.
• W2078239209 cites W2039572620 @default.
• W2078239209 cites W2041045231 @default.
• W2078239209 cites W2042543979 @default.
• W2078239209 cites W2043129828 @default.
• W2078239209 cites W2052111346 @default.
• W2078239209 cites W2056497989 @default.
• W2078239209 cites W2058734537 @default.
• W2078239209 cites W2062873401 @default.
• W2078239209 cites W2064220942 @default.
• W2078239209 cites W2068467951 @default.
• W2078239209 cites W2072435138 @default.
• W2078239209 cites W2072604295 @default.
• W2078239209 cites W2078489634 @default.
• W2078239209 cites W2080571496 @default.
• W2078239209 cites W2087243332 @default.
• W2078239209 cites W2090623565 @default.
• W2078239209 cites W2101000119 @default.
• W2078239209 cites W2106338466 @default.
• W2078239209 cites W2107373225 @default.
• W2078239209 cites W2108740579 @default.
• W2078239209 cites W2115298153 @default.
• W2078239209 cites W2124651752 @default.
• W2078239209 cites W2126661869 @default.
• W2078239209 cites W2127801604 @default.
• W2078239209 cites W2167223464 @default.
• W2078239209 cites W4243749032 @default.
• W2078239209 cites W4252454142 @default.
• W2078239209 cites W4253000766 @default.
• W2078239209 cites W4254882859 @default.
• W2078239209 cites W4254976833 @default.
• W2078239209 cites W4256140942 @default.
• W2078239209 doi "https://doi.org/10.1016/j.yebeh.2006.12.004" @default.
• W2078239209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17258507" @default.
• W2078239209 hasPublicationYear "2007" @default.
• W2078239209 type Work @default.
• W2078239209 sameAs 2078239209 @default.
• W2078239209 citedByCount "11" @default.
• W2078239209 countsByYear W20782392092014 @default.
• W2078239209 countsByYear W20782392092017 @default.
• W2078239209 countsByYear W20782392092018 @default.
• W2078239209 countsByYear W20782392092021 @default.
• W2078239209 countsByYear W20782392092022 @default.
• W2078239209 crossrefType "journal-article" @default.
• W2078239209 hasAuthorship W2078239209A5054440404 @default.
• W2078239209 hasConcept C118552586 @default.
• W2078239209 hasConcept C15744967 @default.
• W2078239209 hasConcept C1862650 @default.
• W2078239209 hasConcept C2776174506 @default.
• W2078239209 hasConcept C2776749334 @default.
• W2078239209 hasConcept C2776809841 @default.
• W2078239209 hasConcept C2777332695 @default.
• W2078239209 hasConcept C2778186239 @default.
• W2078239209 hasConcept C2778802184 @default.
• W2078239209 hasConcept C2780733359 @default.
• W2078239209 hasConcept C2781054738 @default.
• W2078239209 hasConcept C2781246090 @default.
• W2078239209 hasConcept C71924100 @default.
• W2078239209 hasConceptScore W2078239209C118552586 @default.
• W2078239209 hasConceptScore W2078239209C15744967 @default.
• W2078239209 hasConceptScore W2078239209C1862650 @default.
• W2078239209 hasConceptScore W2078239209C2776174506 @default.
• W2078239209 hasConceptScore W2078239209C2776749334 @default.
• W2078239209 hasConceptScore W2078239209C2776809841 @default.
• W2078239209 hasConceptScore W2078239209C2777332695 @default.
• W2078239209 hasConceptScore W2078239209C2778186239 @default.
• W2078239209 hasConceptScore W2078239209C2778802184 @default.

• next